Related Experiment Video
Updated: Jun 26, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Risks associated with statin therapy: a systematic overview of randomized clinical trials
Amir Kashani1, Christopher O Phillips, JoAnne M Foody
1Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Conn, USA.
Circulation
|December 13, 2006
Summary
Statins are generally safe, with no significant increase in muscle or liver damage risks compared to placebo. However, statin therapy is linked to a small rise in transaminase elevations.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Clinical Trials
Background:
- Statins effectively reduce cardiovascular event risk.
- Concerns regarding adverse effects may limit statin prescription.
- This study systematically reviewed statin trials to assess complication risks.
Purpose of the Study:
- To quantify risks of musculoskeletal, renal, and hepatic complications from statin therapy.
- To evaluate the safety profile of statin monotherapy versus placebo in randomized trials.
Main Methods:
- Systematic overview of randomized statin trials (MEDLINE search, 1966-2005).
- Included adults with hyperlipidemia, double-blind statin vs. placebo, >=100 patients.
- Analyzed data on myalgia, creatine kinase, rhabdomyolysis, transaminase elevations, and adverse event discontinuation.
Main Results:
- 74,102 subjects in 35 trials (follow-up 1-65 months).
- No significant increase in myalgias, creatine kinase elevations, rhabdomyolysis, or therapy discontinuation.
- A significant absolute increase in transaminase elevations (RD, 4.2; 95% CI, 1.5 to 6.9) was observed.
Conclusions:
- Statin therapy shows a small excess risk of transaminase elevations, but not myalgias, creatine kinase elevations, rhabdomyolysis, or withdrawal.
- Further research is needed to confirm these findings in routine practice, especially for high-risk patient groups.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...